In addition to his clinical role, Dr. Liu is an active researcher. He aims to develop treatment approaches that stimulate the body's immune system and, in turn, help it to better fight cancer cells. Dr. Liu has received funding for his work from prominent organizations, including the American Cancer Society.
Specialties
Areas of Expertise
Board Certifications
- Hematology
- Medical Oncology
Memberships & Medical Societies
- American Society of Hematology
- American Society of Transplantation and Cellular Therapy
- American Society of Clinical Oncology
Practicing Since
- 2008
Languages Spoken
- English
- Mandarin Chinese
Medical Education
- Beijing Medical University
Residency
- Texas Tech University Health Science Center
Fellowship
- University of Chicago Medicine
Other Grad Education
- Beijing Medical University,PhD
News & Research
View Published Papers- Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
- A Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
- Natural Killer Cell (CYNK-001) Infusions in Adults With AML
- NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS
- IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML
- Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
- Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
- NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
- Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant
- Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation
- Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy
- Combined Haploidentical-Cord Blood Transplantation for Adults and Children
- Aetna HMO (specialists only)
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Aetna Better Health *see insurance page
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- Aetna Medicare Advantage HMO & PPO
- BCBS Medicare Advantage HMO & PPO
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- United Choice HMO (specialists only)
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If your insurance company is not listed here, or if you have any other questions, please contact Managed.Care@uchospitals.edu.
Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
Request an Appointment at Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
To Refer a Patient
Refer a Patient